Cargando…

Identification of novel biomarkers of hepatocellular carcinoma by high‐definition mass spectrometry: Ultrahigh‐performance liquid chromatography quadrupole time‐of‐flight mass spectrometry and desorption electrospray ionization mass spectrometry imaging

RATIONALE: Hepatocellular carcinoma (HCC) is a highly malignant disease for which the development of prospective or prognostic biomarkers is urgently required. Although metabolomics is widely used for biomarker discovery, there are some bottlenecks regarding the comprehensiveness of detected feature...

Descripción completa

Detalles Bibliográficos
Autores principales: Nagai, Koshi, Uranbileg, Baasanjav, Chen, Zhen, Fujioka, Amane, Yamazaki, Takahiro, Matsumoto, Yotaro, Tsukamoto, Hiroki, Ikeda, Hitoshi, Yatomi, Yutaka, Chiba, Hitoshi, Hui, Shu‐Ping, Nakazawa, Toru, Saito, Ritsumi, Koshiba, Seizo, Aoki, Junken, Saigusa, Daisuke, Tomioka, Yoshihisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7154627/
https://www.ncbi.nlm.nih.gov/pubmed/31412144
http://dx.doi.org/10.1002/rcm.8551
_version_ 1783521858064220160
author Nagai, Koshi
Uranbileg, Baasanjav
Chen, Zhen
Fujioka, Amane
Yamazaki, Takahiro
Matsumoto, Yotaro
Tsukamoto, Hiroki
Ikeda, Hitoshi
Yatomi, Yutaka
Chiba, Hitoshi
Hui, Shu‐Ping
Nakazawa, Toru
Saito, Ritsumi
Koshiba, Seizo
Aoki, Junken
Saigusa, Daisuke
Tomioka, Yoshihisa
author_facet Nagai, Koshi
Uranbileg, Baasanjav
Chen, Zhen
Fujioka, Amane
Yamazaki, Takahiro
Matsumoto, Yotaro
Tsukamoto, Hiroki
Ikeda, Hitoshi
Yatomi, Yutaka
Chiba, Hitoshi
Hui, Shu‐Ping
Nakazawa, Toru
Saito, Ritsumi
Koshiba, Seizo
Aoki, Junken
Saigusa, Daisuke
Tomioka, Yoshihisa
author_sort Nagai, Koshi
collection PubMed
description RATIONALE: Hepatocellular carcinoma (HCC) is a highly malignant disease for which the development of prospective or prognostic biomarkers is urgently required. Although metabolomics is widely used for biomarker discovery, there are some bottlenecks regarding the comprehensiveness of detected features, reproducibility of methods, and identification of metabolites. In addition, information on localization of metabolites in tumor tissue is needed for functional analysis. Here, we developed a wide‐polarity global metabolomics (G‐Met) method, identified HCC biomarkers in human liver samples by high‐definition mass spectrometry (HDMS), and demonstrated localization in cryosections using desorption electrospray ionization MS imaging (DESI‐MSI) analysis. METHODS: Metabolic profiling of tumor (n = 38) and nontumor (n = 72) regions in human livers of HCC was performed by an ultrahigh‐performance liquid chromatography quadrupole time‐of‐flight MS (UHPLC/QTOFMS) instrument equipped with a mixed‐mode column. The HCC biomarker candidates were extracted by multivariate analyses and identified by matching values of the collision cross section and their fragment ions on the mass spectra obtained by HDMS. Cryosections of HCC livers, which included both tumor and nontumor regions, were analyzed by DESI‐MSI. RESULTS: From the multivariate analysis, m/z 904.83 and m/z 874.79 were significantly high and low, respectively, in tumor samples and were identified as triglyceride (TG) 16:0/18:1(9Z)/20:1(11Z) and TG 16:0/18:1(9Z)/18:2(9Z,12Z) using the synthetic compounds. The TGs were clearly localized in the tumor or nontumor areas of the cryosection. CONCLUSIONS: Novel biomarkers for HCC were identified by a comprehensive and reproducible G‐Met method with HDMS using a mixed‐mode column. The combination analysis of UHPLC/QTOFMS and DESI‐MSI revealed that the different molecular species of TGs were associated with tumor distribution and were useful for characterizing the progression of tumor cells and discovering prospective biomarkers.
format Online
Article
Text
id pubmed-7154627
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-71546272020-04-14 Identification of novel biomarkers of hepatocellular carcinoma by high‐definition mass spectrometry: Ultrahigh‐performance liquid chromatography quadrupole time‐of‐flight mass spectrometry and desorption electrospray ionization mass spectrometry imaging Nagai, Koshi Uranbileg, Baasanjav Chen, Zhen Fujioka, Amane Yamazaki, Takahiro Matsumoto, Yotaro Tsukamoto, Hiroki Ikeda, Hitoshi Yatomi, Yutaka Chiba, Hitoshi Hui, Shu‐Ping Nakazawa, Toru Saito, Ritsumi Koshiba, Seizo Aoki, Junken Saigusa, Daisuke Tomioka, Yoshihisa Rapid Commun Mass Spectrom Mass Spectrometry for Clinical Diagnosis RATIONALE: Hepatocellular carcinoma (HCC) is a highly malignant disease for which the development of prospective or prognostic biomarkers is urgently required. Although metabolomics is widely used for biomarker discovery, there are some bottlenecks regarding the comprehensiveness of detected features, reproducibility of methods, and identification of metabolites. In addition, information on localization of metabolites in tumor tissue is needed for functional analysis. Here, we developed a wide‐polarity global metabolomics (G‐Met) method, identified HCC biomarkers in human liver samples by high‐definition mass spectrometry (HDMS), and demonstrated localization in cryosections using desorption electrospray ionization MS imaging (DESI‐MSI) analysis. METHODS: Metabolic profiling of tumor (n = 38) and nontumor (n = 72) regions in human livers of HCC was performed by an ultrahigh‐performance liquid chromatography quadrupole time‐of‐flight MS (UHPLC/QTOFMS) instrument equipped with a mixed‐mode column. The HCC biomarker candidates were extracted by multivariate analyses and identified by matching values of the collision cross section and their fragment ions on the mass spectra obtained by HDMS. Cryosections of HCC livers, which included both tumor and nontumor regions, were analyzed by DESI‐MSI. RESULTS: From the multivariate analysis, m/z 904.83 and m/z 874.79 were significantly high and low, respectively, in tumor samples and were identified as triglyceride (TG) 16:0/18:1(9Z)/20:1(11Z) and TG 16:0/18:1(9Z)/18:2(9Z,12Z) using the synthetic compounds. The TGs were clearly localized in the tumor or nontumor areas of the cryosection. CONCLUSIONS: Novel biomarkers for HCC were identified by a comprehensive and reproducible G‐Met method with HDMS using a mixed‐mode column. The combination analysis of UHPLC/QTOFMS and DESI‐MSI revealed that the different molecular species of TGs were associated with tumor distribution and were useful for characterizing the progression of tumor cells and discovering prospective biomarkers. John Wiley and Sons Inc. 2019-11-06 2020-04 /pmc/articles/PMC7154627/ /pubmed/31412144 http://dx.doi.org/10.1002/rcm.8551 Text en © 2019 The Authors. Rapid Communications in Mass Spectrometry published by John Wiley & Sons Ltd This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Mass Spectrometry for Clinical Diagnosis
Nagai, Koshi
Uranbileg, Baasanjav
Chen, Zhen
Fujioka, Amane
Yamazaki, Takahiro
Matsumoto, Yotaro
Tsukamoto, Hiroki
Ikeda, Hitoshi
Yatomi, Yutaka
Chiba, Hitoshi
Hui, Shu‐Ping
Nakazawa, Toru
Saito, Ritsumi
Koshiba, Seizo
Aoki, Junken
Saigusa, Daisuke
Tomioka, Yoshihisa
Identification of novel biomarkers of hepatocellular carcinoma by high‐definition mass spectrometry: Ultrahigh‐performance liquid chromatography quadrupole time‐of‐flight mass spectrometry and desorption electrospray ionization mass spectrometry imaging
title Identification of novel biomarkers of hepatocellular carcinoma by high‐definition mass spectrometry: Ultrahigh‐performance liquid chromatography quadrupole time‐of‐flight mass spectrometry and desorption electrospray ionization mass spectrometry imaging
title_full Identification of novel biomarkers of hepatocellular carcinoma by high‐definition mass spectrometry: Ultrahigh‐performance liquid chromatography quadrupole time‐of‐flight mass spectrometry and desorption electrospray ionization mass spectrometry imaging
title_fullStr Identification of novel biomarkers of hepatocellular carcinoma by high‐definition mass spectrometry: Ultrahigh‐performance liquid chromatography quadrupole time‐of‐flight mass spectrometry and desorption electrospray ionization mass spectrometry imaging
title_full_unstemmed Identification of novel biomarkers of hepatocellular carcinoma by high‐definition mass spectrometry: Ultrahigh‐performance liquid chromatography quadrupole time‐of‐flight mass spectrometry and desorption electrospray ionization mass spectrometry imaging
title_short Identification of novel biomarkers of hepatocellular carcinoma by high‐definition mass spectrometry: Ultrahigh‐performance liquid chromatography quadrupole time‐of‐flight mass spectrometry and desorption electrospray ionization mass spectrometry imaging
title_sort identification of novel biomarkers of hepatocellular carcinoma by high‐definition mass spectrometry: ultrahigh‐performance liquid chromatography quadrupole time‐of‐flight mass spectrometry and desorption electrospray ionization mass spectrometry imaging
topic Mass Spectrometry for Clinical Diagnosis
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7154627/
https://www.ncbi.nlm.nih.gov/pubmed/31412144
http://dx.doi.org/10.1002/rcm.8551
work_keys_str_mv AT nagaikoshi identificationofnovelbiomarkersofhepatocellularcarcinomabyhighdefinitionmassspectrometryultrahighperformanceliquidchromatographyquadrupoletimeofflightmassspectrometryanddesorptionelectrosprayionizationmassspectrometryimaging
AT uranbilegbaasanjav identificationofnovelbiomarkersofhepatocellularcarcinomabyhighdefinitionmassspectrometryultrahighperformanceliquidchromatographyquadrupoletimeofflightmassspectrometryanddesorptionelectrosprayionizationmassspectrometryimaging
AT chenzhen identificationofnovelbiomarkersofhepatocellularcarcinomabyhighdefinitionmassspectrometryultrahighperformanceliquidchromatographyquadrupoletimeofflightmassspectrometryanddesorptionelectrosprayionizationmassspectrometryimaging
AT fujiokaamane identificationofnovelbiomarkersofhepatocellularcarcinomabyhighdefinitionmassspectrometryultrahighperformanceliquidchromatographyquadrupoletimeofflightmassspectrometryanddesorptionelectrosprayionizationmassspectrometryimaging
AT yamazakitakahiro identificationofnovelbiomarkersofhepatocellularcarcinomabyhighdefinitionmassspectrometryultrahighperformanceliquidchromatographyquadrupoletimeofflightmassspectrometryanddesorptionelectrosprayionizationmassspectrometryimaging
AT matsumotoyotaro identificationofnovelbiomarkersofhepatocellularcarcinomabyhighdefinitionmassspectrometryultrahighperformanceliquidchromatographyquadrupoletimeofflightmassspectrometryanddesorptionelectrosprayionizationmassspectrometryimaging
AT tsukamotohiroki identificationofnovelbiomarkersofhepatocellularcarcinomabyhighdefinitionmassspectrometryultrahighperformanceliquidchromatographyquadrupoletimeofflightmassspectrometryanddesorptionelectrosprayionizationmassspectrometryimaging
AT ikedahitoshi identificationofnovelbiomarkersofhepatocellularcarcinomabyhighdefinitionmassspectrometryultrahighperformanceliquidchromatographyquadrupoletimeofflightmassspectrometryanddesorptionelectrosprayionizationmassspectrometryimaging
AT yatomiyutaka identificationofnovelbiomarkersofhepatocellularcarcinomabyhighdefinitionmassspectrometryultrahighperformanceliquidchromatographyquadrupoletimeofflightmassspectrometryanddesorptionelectrosprayionizationmassspectrometryimaging
AT chibahitoshi identificationofnovelbiomarkersofhepatocellularcarcinomabyhighdefinitionmassspectrometryultrahighperformanceliquidchromatographyquadrupoletimeofflightmassspectrometryanddesorptionelectrosprayionizationmassspectrometryimaging
AT huishuping identificationofnovelbiomarkersofhepatocellularcarcinomabyhighdefinitionmassspectrometryultrahighperformanceliquidchromatographyquadrupoletimeofflightmassspectrometryanddesorptionelectrosprayionizationmassspectrometryimaging
AT nakazawatoru identificationofnovelbiomarkersofhepatocellularcarcinomabyhighdefinitionmassspectrometryultrahighperformanceliquidchromatographyquadrupoletimeofflightmassspectrometryanddesorptionelectrosprayionizationmassspectrometryimaging
AT saitoritsumi identificationofnovelbiomarkersofhepatocellularcarcinomabyhighdefinitionmassspectrometryultrahighperformanceliquidchromatographyquadrupoletimeofflightmassspectrometryanddesorptionelectrosprayionizationmassspectrometryimaging
AT koshibaseizo identificationofnovelbiomarkersofhepatocellularcarcinomabyhighdefinitionmassspectrometryultrahighperformanceliquidchromatographyquadrupoletimeofflightmassspectrometryanddesorptionelectrosprayionizationmassspectrometryimaging
AT aokijunken identificationofnovelbiomarkersofhepatocellularcarcinomabyhighdefinitionmassspectrometryultrahighperformanceliquidchromatographyquadrupoletimeofflightmassspectrometryanddesorptionelectrosprayionizationmassspectrometryimaging
AT saigusadaisuke identificationofnovelbiomarkersofhepatocellularcarcinomabyhighdefinitionmassspectrometryultrahighperformanceliquidchromatographyquadrupoletimeofflightmassspectrometryanddesorptionelectrosprayionizationmassspectrometryimaging
AT tomiokayoshihisa identificationofnovelbiomarkersofhepatocellularcarcinomabyhighdefinitionmassspectrometryultrahighperformanceliquidchromatographyquadrupoletimeofflightmassspectrometryanddesorptionelectrosprayionizationmassspectrometryimaging